Clinical Trial Update: Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intensity-modulated radiation therapy with gemcitabine for locally advanced pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED